New online program aims to cut stress for young lupus and dermatomyositis patients

NCT ID NCT06999109

First seen May 27, 2026 · Last updated Jun 20, 2026 · Updated 8 times

Summary

This study tests an online, self-guided program called TEAM-LEADS designed to help teens and young adults (ages 13-22) with lupus or dermatomyositis reduce stress and adopt heart-healthy behaviors. Researchers at Duke University will enroll 25 participants to see if the program is feasible and acceptable. The study focuses on measuring changes in stress levels and cardiovascular health habits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

TEAM-LEADS online stress-reduction program

What this could lead to

If it works, this could provide a practical, online tool to help young people with lupus or dermatomyositis manage stress and improve heart-healthy habits.

What could go wrong

This is a very small, early feasibility study with only 25 participants. It is not designed to prove the program works, only that it is acceptable and possible to use. Results may not apply to everyone.

Conditions

The condition(s) this trial relates to.

anxiety disorder Depression dermatomyositis Health Behavior Motor Activity systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.